Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment
Editorial summary Specific prophylactic migraine treatments are urgently needed because of the unmet needs of many migraine patients. Antibodies targeting calcitonin gene-related peptide (CGRP) or its receptor have recently shown efficacy in episodic and chronic migraine and will be available soon.
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2018-02-01
|
| Series: | Genome Medicine |
| Online Access: | http://link.springer.com/article/10.1186/s13073-018-0524-7 |